Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
La Shell
Mark S
MS
Calabria
Christopher W
CW
D000284:Administration, Oral; D000286:Administration, Sublingual; D000485:Allergens / Q000008:administration & dosage*; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000379:methods*; D006801:Humans
D000485:Allergens